Broker Ratings

Tenet Healthcare Corporation – Consensus ‘buy’ rating and 36.4% Upside Potential

Tenet Healthcare Corporation which can be found using ticker (THC) now have 20 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $217.00 and $134.00 suggesting an average Analsyt target price of $172.16. Now with the previous closing price of $126.19 this indicates there is a potential upside of 36.4%. The day 50 moving average is $134.36 and the 200 moving average now moves to $143.52. The total market capitalization for the company now stands at 12.70B. The price for the stock stands currently at: $133.57 USD

The potential market cap would be $17,329,381,697 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 4.08, revenue per share of $213.20 and a 6.99% return on assets.

Tenet Healthcare Corporation is a diversified healthcare services company. Through its subsidiaries, partnerships and joint ventures, including USPI Holding Company, Inc. (USPI), it operates approximately 61 acute care and specialty hospitals, as well as over 575 other healthcare facilities, including surgical hospitals, ambulatory surgery centers (ASC), imaging centers, off-campus emergency departments (ED) and micro-hospitals. The Company operates through three segments: Hospital Operations, Ambulatory Care segment and Conifer. Its Hospital Operations segment includes its acute care and specialty hospitals, imaging centers, ancillary outpatient facilities, micro hospitals and physician practices. Its Ambulatory Care segment consists of USPI’s ASCs and surgical hospitals. Its Conifer segment provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers and other clients through its Conifer Holdings, Inc. subsidiary.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

    Tenet Healthcare Corporation (NYSE: THC), a major player in the United States healthcare sector, is capturing investor attention with its robust market performance and promising growth potential. Operating across two

    Tenet Healthcare Corporation (THC): Stock Analysis Reveals 5.64% Potential Upside and Strong Buy Consensus

    Tenet Healthcare Corporation (NYSE: THC) is making waves in the healthcare sector, boasting a market capitalization of $17.67 billion and a robust operational framework. With a presence across the United

    Tenet Healthcare Corporation (THC) Stock Analysis: Strong Analyst Ratings and Potential 8% Upside

    Tenet Healthcare Corporation (NYSE: THC) stands as a notable player in the healthcare sector, operating within the medical care facilities industry. Headquartered in Dallas, Texas, and with a market capitalization

    Tenet Healthcare Corporation (THC) Stock Analysis: Navigating Strong Sector Potential Amidst Market Challenges

    Tenet Healthcare Corporation (NYSE: THC) stands as a significant player within the U.S. healthcare sector, commanding a robust market capitalization of $17.94 billion. With a diverse operational footprint, Tenet offers

    Tenet Healthcare Corporation (THC) Stock Analysis: A 202 USD Peak and Its Strategic Growth Potential

    Tenet Healthcare Corporation (NYSE: THC) stands as a robust player in the healthcare sector within the United States, commanding a market capitalization of $17.85 billion. This diversified healthcare services provider,

    Tenet Healthcare Corporation (THC) Stock Analysis: Riding the Peak with Strategic Growth and Robust Investor Confidence

    Investors and healthcare enthusiasts, take note: Tenet Healthcare Corporation (NYSE: THC) is catching the spotlight with its strategic growth initiatives and robust market performance. As of now, Tenet’s stock is

      Search

      Search